Open Beta
MetriLume

US marketsGRDN

SEC-sourced researchBeta

GRDN

Guardian Pharmacy Services, Inc.

Company comparison ↗

Data passport

CIK
0001802255
Exchange
NYSE
Business activity
— · SIC 5912
Financial inputs
6/6
Filing date
Sep 28, 2026
SEC registry record
Operating company

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 1,228,409,000.0000 USD; December 2025: 1,448,685,000.0000 USD1.4B USD0 USD0December 2024December 2025
GRDN · Exact amounts and source periods · USD
Period endRevenueFiling date
December 20241,228,409,000.0000Mar 11, 2026
December 20251,448,685,000.0000Mar 11, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 20251,448,685,000.000049,219,000.0000100,255,000.0000412,658,000.0000194,734,000.0000Mar 11, 2026
December 20241,228,409,000.0000-110,047,000.000057,960,000.0000320,810,000.0000170,834,000.0000Mar 11, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenues$1.45BDecember 2025Mar 11, 202610-K
Previous period revenueRevenues$1.23BDecember 2024Mar 11, 202610-K
Net incomeNetIncomeLoss$49.22MDecember 2025Mar 11, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities$100.26MDecember 2025Mar 11, 202610-K
Total assetsAssets$412.66MDecember 2025Mar 11, 202610-K
Total liabilitiesLiabilities$194.73MDecember 2025Mar 11, 202610-K

New filings

Explore methodology ↗